Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Ji-young-
dc.contributor.authorShim, Gayong-
dc.contributor.authorChoi, Hyun-woo-
dc.contributor.authorPark, Jooho-
dc.contributor.authorChung, Seung Woo-
dc.contributor.authorKim, Sunil-
dc.contributor.authorKim, Kwangmeyung-
dc.contributor.authorKwon, Ick Chan-
dc.contributor.authorKim, Chan-Wha-
dc.contributor.authorKim, Sang Yoon-
dc.contributor.authorYang, Victor C.-
dc.contributor.authorOh, Yu-Kyoung-
dc.contributor.authorByun, Youngro-
dc.date.accessioned2021-09-06T19:07:38Z-
dc.date.available2021-09-06T19:07:38Z-
dc.date.created2021-06-18-
dc.date.issued2012-06-
dc.identifier.issn0142-9612-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/108246-
dc.description.abstractThe chemical conjugate of low molecular weight heparin with taurocholate (LHT7) was previously designed to offer anticancer activity while minimizing the anticoagulant activity. In the present study, we found that the systemic administration of LHT7 in nanolipoplex could substantially enhance tumor vasculature targeting and anticancer effects. Moreover, we found that co-delivery of LHT7 with suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, in nanolipoplex could provide synergistic antitumor effect. LHT7/SAHA nanolipoplex was formulated by encapsulating SAHA inside cationic liposomes, followed by complexation of negatively charged LHT7 onto the cationic surfaces of SAHA-loaded liposomes (SAHA-L). LHT7/SAHA nanolipoplex was positively charged with a mean diameter of 117.6 nm, and stable in serum. The nanolipoplex form of LHT7 could alter its pharmacokinetics and biodistribution. Compared to the free form of LHT7, LHT7 in the nanolipoplex showed 1.9-fold higher mean residence time, and higher tumor vasculature accumulation after its intravenous administration. LHT7/SAHA nanolipoplex showed highest antitumor efficacy in SCC-bearing mice, compared to LHT7, SAHA-L and sequential co-administration of LHT7 and SAHA-L Consistent with the enhanced antitumor effect, the reduction of abnormal vessels in the tumor site was also the highest in the LHT7/SAHA nanolipoplex-treated group. These results suggested the potential of LHT7/SAHA nanolipoplex for enhanced tumor vasculature targeting, and the importance of nanolipoplex-mediated co-delivery with a histone deacetylase inhibitor for maximal anticancer effect. (C) 2012 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.subjectHISTONE DEACETYLASE INHIBITORS-
dc.subjectCLINICAL-TRIALS-
dc.subjectCANCER-THERAPY-
dc.subjectLIPOSOMES-
dc.subjectANGIOGENESIS-
dc.subjectLIPOPLEXES-
dc.subjectEFFICACY-
dc.subjectINCREASE-
dc.subjectVESSELS-
dc.subjectSURFACE-
dc.titleTumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex-
dc.typeArticle-
dc.contributor.affiliatedAuthorKwon, Ick Chan-
dc.contributor.affiliatedAuthorKim, Chan-Wha-
dc.identifier.doi10.1016/j.biomaterials.2012.02.066-
dc.identifier.scopusid2-s2.0-84862809560-
dc.identifier.wosid000303181500019-
dc.identifier.bibliographicCitationBIOMATERIALS, v.33, no.17, pp.4424 - 4430-
dc.relation.isPartOfBIOMATERIALS-
dc.citation.titleBIOMATERIALS-
dc.citation.volume33-
dc.citation.number17-
dc.citation.startPage4424-
dc.citation.endPage4430-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaEngineering-
dc.relation.journalResearchAreaMaterials Science-
dc.relation.journalWebOfScienceCategoryEngineering, Biomedical-
dc.relation.journalWebOfScienceCategoryMaterials Science, Biomaterials-
dc.subject.keywordPlusHISTONE DEACETYLASE INHIBITORS-
dc.subject.keywordPlusCLINICAL-TRIALS-
dc.subject.keywordPlusCANCER-THERAPY-
dc.subject.keywordPlusLIPOSOMES-
dc.subject.keywordPlusANGIOGENESIS-
dc.subject.keywordPlusLIPOPLEXES-
dc.subject.keywordPlusEFFICACY-
dc.subject.keywordPlusINCREASE-
dc.subject.keywordPlusVESSELS-
dc.subject.keywordPlusSURFACE-
dc.subject.keywordAuthorHeparin-taurocholate conjugate-
dc.subject.keywordAuthorAngiogenesis inhibitor-
dc.subject.keywordAuthorHistone deacetylase inhibitor-
dc.subject.keywordAuthorCationic nanolipoplex-
dc.subject.keywordAuthorTumor vasculature targeting-
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > KU-KIST Graduate School of Converging Science and Technology > 1. Journal Articles
College of Life Sciences and Biotechnology > Division of Life Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE